Literature DB >> 33638891

Pre-eclampsia and long-term health outcomes for mother and infant: an umbrella review.

T Pittara1, A Vyrides2, D Lamnisos1, K Giannakou1.   

Abstract

BACKGROUND: Pre-eclampsia is a pregnancy-associated condition with complex disease mechanisms and a risk factor for various long-term health outcomes for the mother and infant.
OBJECTIVE: To summarise evidence on the association of pre-eclampsia with long-term health outcomes arising in women and/or infants. SEARCH STRATEGY: PubMed, EMBASE, Scopus and ISI Web of Science were searched from inception to July 2020. SELECTION CRITERIA: Systematic reviews and meta-analyses examining associations between pre-eclampsia and long-term health outcomes in women and their infants. DATA COLLECTION AND ANALYSIS: Data were extracted by two independent reviewers. We re-estimated the summary effect size by random-effects and fixed-effects models, the 95% confidence interval, the 95% prediction interval, the between-study heterogeneity, any evidence of small-study effects and excess significance bias.
RESULTS: Twenty-one articles were included (90 associations). Seventy-nine associations had nominally statistically significant findings (P < 0.05). Sixty-five associations had large or very large heterogeneity. Evidence for small-study effects and excess significance bias was found in seven and two associations, respectively. Nine associations: cerebrovascular disease (cohort studies), cerebrovascular disease (overall), cardiac disease (cohort studies), dyslipidaemia (all studies), risk of death (late-onset pre-eclampsia), fatal and non-fatal ischaemic heart disease, cardiovascular mortality (cohort studies), any diabetes or use of diabetic medication (unadjusted), and attention deficit/hyperactivity disorder (ADHD) (adjusted) were supported with robust evidence.
CONCLUSION: Many of the meta-analyses in this research field have caveats casting doubts on their validity. Current evidence suggests an increased risk for women to develop cardiovascular-related diseases, diabetes and dyslipidaemia after pre-eclampsia, while offspring exposed to pre-eclampsia are at higher risk for ADHD. TWEETABLE ABSTRACT: Cardiovascular and cerebrovascular diseases were supported with convincing evidence for long-term health outcomes after pre-eclampsia.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  Epidemiological credibility; health outcomes; meta-analysis; pre-eclampsia; umbrella review

Year:  2021        PMID: 33638891     DOI: 10.1111/1471-0528.16683

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  12 in total

Review 1.  Preeclampsia and eclampsia: the conceptual evolution of a syndrome.

Authors:  Offer Erez; Roberto Romero; Eunjung Jung; Piya Chaemsaithong; Mariachiara Bosco; Manaphat Suksai; Dahiana M Gallo; Francesca Gotsch
Journal:  Am J Obstet Gynecol       Date:  2022-02       Impact factor: 8.661

2.  Elastin-Like Polypeptide: VEGF-B Fusion Protein for Treatment of Preeclampsia.

Authors:  Jamarius P Waller; John Aaron Howell; Hali Peterson; Eric M George; Gene L Bidwell
Journal:  Hypertension       Date:  2021-11-01       Impact factor: 10.190

Review 3.  Methodological approaches for assessing certainty of the evidence in umbrella reviews: A scoping review.

Authors:  Saranrat Sadoyu; Kaniz Afroz Tanni; Nontaporn Punrum; Sobhon Paengtrai; Warittakorn Kategaew; Nattiwat Promchit; Nai Ming Lai; Ammarin Thakkinstian; Surachat Ngorsuraches; Mukdarut Bangpan; Sajesh Veettil; Nathorn Chaiyakunapruk
Journal:  PLoS One       Date:  2022-06-08       Impact factor: 3.752

4.  Management and outcomes of extreme preterm birth.

Authors:  Andrei S Morgan; Marina Mendonça; Nicole Thiele; Anna L David
Journal:  BMJ       Date:  2022-01-10

5.  Dysregulated non-coding telomerase RNA component and associated exonuclease XRN1 in leucocytes from women developing preeclampsia-possible link to enhanced senescence.

Authors:  Tove Lekva; Marie Cecilie Paasche Roland; Mette E Estensen; Errol R Norwitz; Tamara Tilburgs; Tore Henriksen; Jens Bollerslev; Kjersti R Normann; Per Magnus; Ole Kristoffer Olstad; Pål Aukrust; Thor Ueland
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

6.  The Effect of Selenium Supplementation on Clinical Outcomes, Metabolic Profiles, and Pulsatility Index of the Uterine Artery in High-Risk Mothers in Terms of Preeclampsia Screening with Quadruple Test: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial : Selenium and preeclampsia.

Authors:  Elahe Mesdaghinia; Farah Shahin; Amir Ghaderi; Daryoush Shahin; Mohammad Shariat; Hamidreza Banafshe
Journal:  Biol Trace Elem Res       Date:  2022-02-28       Impact factor: 3.738

Review 7.  Identification of Biomarkers for Preeclampsia Based on Metabolomics.

Authors:  Mengxin Yao; Yue Xiao; Zhuoqiao Yang; Wenxin Ge; Fei Liang; Haoyue Teng; Yingjie Gu; Jieyun Yin
Journal:  Clin Epidemiol       Date:  2022-03-19       Impact factor: 4.790

8.  Is the risk of cardiovascular disease in women with pre-eclampsia modified by very low or very high offspring birth weight? A nationwide cohort study in Norway.

Authors:  Hilde Kristin Refvik Riise; Jannicke Igland; Gerhard Sulo; Marjolein Memelink Iversen; Marit Graue; Anne Eskild; Grethe Seppola Tell; Anne Kjersti Daltveit
Journal:  BMJ Open       Date:  2022-04-26       Impact factor: 3.006

9.  Using network analysis to illuminate the intergenerational transmission of adversity.

Authors:  Chad Lance Hemady; Lydia Gabriela Speyer; Janell Kwok; Franziska Meinck; G J Melendez-Torres; Deborah Fry; Bonnie Auyeung; Aja Louise Murray
Journal:  Eur J Psychotraumatol       Date:  2022-08-18

10.  Information needs and experiences from pregnancies complicated by hypertensive disorders: a qualitative analysis of narrative responses.

Authors:  Raj Shree; Kendra Hatfield-Timajchy; Alina Brewer; Eleni Tsigas; Marianne Vidler
Journal:  BMC Pregnancy Childbirth       Date:  2021-11-02       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.